Why is $ACTU stock down today?
Actuate Therapeutics, Inc. Common stock
Why is $ACTU down today?
The likely driver
Actuate Therapeutics Announces ASCO Poster Presentations Demonstrating Compelling Clinical and Biomarker Data for Elraglusib in First-Line Metastatic Pancreatic Cancer
GlobeNewswire Inc.·7:00 AM ETpositive
Price
$1.71
Move today
-7.0%
Volume vs avg
0.0x
Scanner alerts today
0
Move and volume are based on the latest market data and refresh live on this page. Scanner alerts are our own real-time unusual-volume signals. This is research, not investment advice.